☆ 4.2 Letter

Neurological effects of elevated levels of angiotensin II in COVID-19 patients

HUMAN CELL (2021)

Journal

HUMAN CELL

Volume 34, Issue 6, Pages 1941-1942

Publisher

SPRINGER JAPAN KK

DOI: 10.1007/s13577-021-00605-0

Keywords

Angiotensin II; COVID-19; SARS-CoV-2

Categories

Cell Biology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Endocrinology & Metabolism

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?

Yue Hu, Lihuan Liu, Xifeng Lu

Summary: ACE2, a negative regulator of the renin-angiotensin system, is the receptor for SARS-CoV-2 and plays a crucial role in the pathophysiology of COVID-19. It is implicated in tissue injury, chronic conditions such as hypertension, diabetes, and cardiovascular disease, and may be a potential therapeutic target for COVID-19.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies

Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natalia Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Muhammad, Siew Hua Gan, Aliyu Ibrahim Dabai, M. Alblihed, Arabinda Ghosh, Reem H. Badr, Devarajan Thangadurai, Mustapha Umar Imam

Summary: COVID-19 is a potentially fatal multisystemic infection caused by SARS-CoV-2, with a lack of cost-effective, safe, and readily available therapeutic options. Traditional herbs used in African and Asian regions may contribute to a lesser burden of the pandemic. Ethnomedicinal plants containing bioactive compounds could potentially mitigate COVID-19 by modulating ACE2 activity.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Environmental Sciences

Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission

Nguyen Thanh Tung, Po-Ching Cheng, Kai-Hsien Chi, Ta-Chi Hsiao, Timothy Jones, Kelly BeruBe, Kin-Fai Ho, Hsiao-Chi Chuang

Summary: COVID-19 caused by SARS-CoV-2 has become a global pandemic. Particulate matter (PM) may act as a carrier for SARS-CoV-2 transmission, with PM increasing the expression of ACE2 in the lungs, facilitating viral adhesion. This suggests that PM could be a direct and indirect transmission model for SARS-CoV-2 infection.

SCIENCE OF THE TOTAL ENVIRONMENT (2021)

Add to Collection

Review Immunology

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19

Keiji Kuba, Tomokazu Yamaguchi, Josef M. Penninger

Summary: Seventeen years after the SARS epidemic, the emergence of the novel coronavirus SARS-CoV-2 has led to an unprecedented pandemic. ACE2 plays a crucial role in cell entry of SARS-CoV-2 and its high affinity to ACE2 results in increased infectivity and transmissibility. In addition to serving as the receptor for SARS-CoV-2, ACE2 also plays an important role in various aspects of COVID-19 pathogenesis and potential post-COVID-19 syndromes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19

Graham J. Moore, Jose M. Pires, Konstantinos Kelaidonis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, John M. Matsoukas

Summary: The study explores the charge relay system in Angiotensin II and its activation mechanism involving different amino acids, as well as how recent crystallography studies have shed light on angiotensin receptor blockers. The research also demonstrates the protective effects of ARBs in hypertensive patients infected with SARS-CoV-2 and proposes the potential of using ARBs to target and prevent cytokine storms in the disease.

BIOMOLECULES (2021)

Add to Collection

Review Medicine, General & Internal

Covid-19 Vaccines - Immunity, Variants, Boosters

Dan H. Barouch

Summary: This article reviews the protective effects of vaccination and prior infection on severe Covid-19, and proposes future research directions.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome

Qin Liu, Qi Su, Fen Zhang, Hein M. Tun, Joyce Wing Yan Mak, Grace Chung-Yan Lui, Susanna So Shan Ng, Jessica Y. L. Ching, Amy Li, Wenqi Lu, Chenyu Liu, Chun Pan Cheung, David S. C. Hui, Paul K. S. Chan, Francis Ka Leung Chan, Siew C. Ng

Summary: By integrating clinical features and multi-omics data, the authors identified specific gut microbiome patterns associated with disease severity and development of post-acute COVID-19 syndrome. These findings highlight the potential utility of host phenotype and multi-kingdom microbiota profiling as a prognostic tool for patients with COVID-19.

NATURE COMMUNICATIONS (2022)

Add to Collection

Editorial Material Immunology

Transition to endemicity: Understanding COVID-19

Rustom Antia, M. Elizabeth Halloran

Summary: The article discusses the basic concepts underlying the transition from an epidemic to an endemic state, as well as the implications of this transition for COVID-19.

IMMUNITY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia

Francesca Lunardi, Francesco Fortarezza, Luca Vedovelli, Federica Pezzuto, Annalisa Boscolo, Marco Rossato, Roberto Vettor, Anna Maria Cattelan, Claudia Del Vecchio, Andrea Crisanti, Paolo Navalesi, Dario Gregori, Fiorella Calabrese

Summary: This study found that ACE-2 levels were decreased in lung tissue of smokers, and smoking was the most probable risk factor associated with low ACE-2 expression. Additionally, there was a direct relationship between viral quantity and ACE-2 expression, with high ACE-2 expressors more likely to show vascular injury.

BIOMOLECULES (2021)

Add to Collection

Article Immunology

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients

Ikram Omar Osman, Clea Melenotte, Philippe Brouqui, Matthieu Million, Jean-Christophe Lagier, Philippe Parola, Andreas Stein, Bernard La Scola, Line Meddeb, Jean-Louis Mege, Didier Raoult, Christian A. Devaux

Summary: SARS-CoV-2 infection can lead to variations in ACE2 expression and Ang II plasma concentration, potentially affecting blood pressure regulation and COVID-19 outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Spatiotemporal pattern of COVID-19 spread in Brazil

Marcia C. Castro, Sun Kim, Lorena Barberia, Ana Freitas Ribeiro, Susie Gurzenda, Karina Braga Ribeiro, Erin Abbott, Jeffrey Blossom, Beatriz Rache, Burton H. Singer

Summary: The study found that COVID-19 in Brazil is spreading rapidly across municipalities with distinct spatial and temporal patterns of clustering, trajectories, and speed. Analysis shows that inadequate policy measures have led to high transmission and mortality burdens. The current surge in cases and deaths, along with the circulation of concerning variants, highlights the need for government to strengthen prevention and control measures.

SCIENCE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Translating bioactive peptides for COVID-19 therapy

Khushwant S. Bhullar, Steven J. Drews, Jianping Wu

Summary: COVID-19, caused by SARS-CoV-2, is a global pandemic threatening health, social stability, and the economy. This article discusses the potential of bioactive peptides in mitigating SARS-CoV-2 infection through inhibiting specific targets like TMPRSS2 and furin cleavage.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia, Jason Morris, Gregory Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, Andrew C. Adams, Jacob Van Naarden, Kenneth L. Custer, Lei Shen, Michael Durante, Gerard Oakley, Andrew E. Schade, Janelle Sabo, Dipak R. Patel, Paul Klekotka, Daniel M. Skovronsky

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, Bronwen E. Lambson, Tulio de Oliveira, Marion Vermeulen, Karin van der Berg, Theresa Rossouw, Michael Boswell, Veronica Ueckermann, Susan Meiring, Anne von Gottberg, Cheryl Cohen, Lynn Morris, Jinal N. Bhiman, Penny L. Moore

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees

Emanuele Andreano, Ida Paciello, Silvia Marchese, Lorena Donnici, Giulio Pierleoni, Giulia Piccini, Noemi Manganaro, Elisa Pantano, Valentina Abbiento, Piero Pileri, Linda Benincasa, Ginevra Giglioli, Margherita Leonardi, Piet Maes, Concetta De Santi, Claudia Sala, Emanuele Montomoli, Raffaele De Francesco, Rino Rappuoli

Summary: In this study, Andreano and Paciello et al. provide insights into the functional and genetic characteristics of the Omicron BA.1 and BA.2 cross-protective antibody response. Their findings reveal that SARS-CoV-2 vaccines can induce neutralizing antibodies that cross-neutralize the Omicron variants and SARS-CoV-1 virus.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Cell Biology

The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments

Mohammad Rafi Khezri, Keyvan Yousefi, Ayda Esmaeili, Morteza Ghasemnejad-Berenji

Summary: This review summarizes the potential roles of ERK1/2 in the pathophysiology of Alzheimer's disease.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

Add to Collection

Article Medicine, Research & Experimental

Bmal1 and Gut-lung axis in SARS-CoV-2 infection: New insight into the effects of melatonin on COVID-19 patients?

Mohammad Rafi Khezri, Reza Varzandeh, Morteza Ghasemnejad-Berenji

Summary: Coronavirus disease 2019 (COVID-19) is a global challenge. Recent studies have found a significant association between gut microbiota and SARS-CoV-2 infection, but the exact mechanism is unknown. This paper aims to introduce a possible molecular mechanism based on the association between circadian rhythm and gut flora in COVID-19 patients, providing new insights into the potential mechanism of melatonin in protecting against SARS-CoV-2 infection.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Review Neurosciences

The Role of Caspases in Alzheimer's Disease: Pathophysiology Implications and Pharmacologic Modulation

Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji

Summary: Alzheimer's disease is the most common neurodegenerative disorder worldwide and its main cause is still unknown. Neuronal death due to various pathologic changes is considered to be the main cause. Caspases, a group of proteases involved in cellular apoptosis and other cellular responses, have been found to play a central role in the pathophysiology of Alzheimer's disease. Targeting caspases may be a suitable therapeutic option to slow the progression of the disease.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Review Cell Biology

Therapeutic potential of ADAM10 modulation in Alzheimer's disease: a review of the current evidence

Mohammad Rafi Khezri, Mehdi Mohebalizadeh, Morteza Ghasemnejad-Berenji

Summary: Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide, characterized by neuronal and synaptic loss in the central nervous system. The major causes of neuronal death in AD include accumulation of extracellular amyloid beta (Aβ) and aggregated tau proteins. Targeting the process of Aβ production to reduce its deposition has emerged as a potential therapeutic option for AD management. This review focuses on ADAM10, a protein involved in the non-amyloidogenic pathway of amyloid precursor protein processing, and discusses its molecular properties, role in AD, and potential as a therapeutic target to slow down disease progression.

CELL COMMUNICATION AND SIGNALING (2023)

Add to Collection

Editorial Material Neurosciences

The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?

Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji, Donya Moloodsouri

Summary: One of the main players in apoptosis during Alzheimer's disease progression are different members of caspase family of proteases, with caspase-3 being the most well-known. The PI3K/AKT signaling pathway is the most important intracellular factor involved in regulating caspase-3 activity. This commentary aims to highlight the possible relations between the PI3K/AKT signaling pathway and caspase-3 in Alzheimer's disease.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Article Pediatrics

Protective effects of empagliflozin on testicular injury induced by torsion/ detorsion in adult male rats

Mohammad Rafi Khezri, Hojjat Ghasemnejad-Berenji, Morteza Ghasemnejad-Berenji

Summary: The study demonstrated that empagliflozin effectively reduces oxidative stress induced by testicular torsion, leading to tissue protection and improvement in testicular damage caused by torsion/detorsion.

JOURNAL OF PEDIATRIC UROLOGY (2023)

Add to Collection

Article Oncology

Protective effects of sitagliptin on methotrexate-induced nephrotoxicity in rats

Leila Afkhami Fard, Hassan Malekinejad, Zeinab Esmaeilzadeh, Abbas Jafari, Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji

Summary: The study aimed to investigate the protective effect of sitagliptin on methotrexate-induced nephrotoxicity in rats. The results showed that sitagliptin effectively attenuated the kidney injury caused by methotrexate and exhibited potent antioxidant properties.

JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-TOXICOLOGY AND CARCINOGENESIS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association

Mohammad Rafi Khezri, Ayda Esmaeili, Morteza Ghasemnejad-Berenji

Summary: Recent studies have revealed the significant role of gut microbiota and circadian rhythm in the pathophysiology of Alzheimer's disease and Parkinson's disease.

ACS CHEMICAL NEUROSCIENCE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats

Fereshteh Nazari-Khanamiri, Abbas Jafari, Zeinab Esmaeilzadeh, Morteza Ghasemnejad-Berenji

Summary: The study demonstrated that EMPA has a protective effect against acetic acid-induced colitis in rats, which may be related to its antioxidative effects.

BMC GASTROENTEROLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Quercetin and Heart Health: From Molecular Pathways to Clinical Findings

Fereshteh Nazari-Khanamiri, Morteza Ghasemnejad-Berenji

Summary: Cardiovascular diseases are the leading causes of global death and are increasing over time. Quercetin has various beneficial effects on the cardiovascular system, including anti-inflammatory, vasodilatory, and antihypertensive effects. It can also protect myocardial cells from oxidative stress and inflammation.

JOURNAL OF FOOD BIOCHEMISTRY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Protective effects of topiramate on acetic acid-induced colitis in rats through the inhibition of oxidative stress

Reza Varzandeh, Mohammad Rafi Khezri, Zeinab Esmaeilzadeh, Abbas Jafari, Morteza Ghasemnejad-Berenji

Summary: This study aimed to examine the protective effects of topiramate on acetic acid-induced ulcerative colitis in rats. The results showed that topiramate significantly reduced colonic lesions, improved histopathologic changes, and increased the activity of antioxidant enzymes. Therefore, topiramate may be an effective therapeutic candidate for reducing the severity of ulcerative colitis.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Add to Collection

Review Chemistry, Medicinal

The pharmacological effects of Berberine and its therapeutic potential in different diseases: Role of the phosphatidylinositol 3-kinase/AKT signaling pathway

Mohammad Rafi Khezri, Somayeh Mohammadipanah, Morteza Ghasemnejad-Berenji

Summary: The PI3K/AKT signaling pathway is crucial for cell growth and survival, and Berberine, a natural compound, modulates this pathway to exhibit anti-inflammatory, antioxidant, antidiabetic, and antitumor effects.

PHYTOTHERAPY RESEARCH (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.